Facebook Twitter RSS Feed
 - breast cancer pink ribbon

The genetic tests clinicians use to diagnose and stratify breast cancer are getting increasingly complex and studies show that there may be some discordance between generations when assessing a woman’s risk of cancer recurrence. Molecular subtyping may be the only way to get clarity on the matter.

 - alzheimer's disease

Typical Alzheimer’s neuroimaging looks at amyloid deposition and neurofibrillary tangles, but a new quantitative method uses arterial input to bring signs of functional disease into sharper relief, according to a study published April 16 in the Journal of Nuclear Medicine.

 - PCOS theca cell

If an ovarian cell carries a certain genetic variant it could spell an excess of androgens much like testosterone in women with polycystic ovary syndrome, making it more difficult for them to conceive. This revelation could eventually lead to a diagnostic test and treatment, according to an announcement yesterday from the National Institutes of Health.

 - Gavel and stethoscope

Medical malpractice claims and costs are likely to rise as changes from the Patient Protection and Affordable Care Act take effect, an analysis by RAND Corp. predicted.

 - fMRI schizophrenia

A partnership between the Broad Institute’s Stanley Center for Psychiatric Research in Cambridge, Mass., and Tetra Discovery Partners based in Grand Rapids, Mich., that pores over the human genome for specific variants in schizophrenia may make way for new pharmaceutical therapies for psychiatric disease, Tetra announced April 9.